Home/Pipeline/CAR‑iNK‑TNBC

CAR‑iNK‑TNBC

Triple‑Negative Breast Cancer

PreclinicalActive

Key Facts

Indication

Triple‑Negative Breast Cancer

Phase

Preclinical

Status

Active

Company

About Cartherics

Australian biotech delivering off‑the‑shelf CAR‑NK and EV immunotherapies for women’s cancers and endometriosis.

View full company profile

Therapeutic Areas

Oncology Gynecology Immunology